Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 19

1.

LRP1 Protein Deficiency Exacerbates Palmitate-induced Steatosis and Toxicity in Hepatocytes.

Hamlin AN, Basford JE, Jaeschke A, Hui DY.

J Biol Chem. 2016 Aug 5;291(32):16610-9. doi: 10.1074/jbc.M116.717744. Epub 2016 Jun 17.

PMID:
27317662
2.

Histopathology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.

Brown GT, Kleiner DE.

Metabolism. 2016 Aug;65(8):1080-6. doi: 10.1016/j.metabol.2015.11.008. Epub 2015 Dec 2. Review.

PMID:
26775559
3.

Association between vitamin E and non-alcoholic steatohepatitis: a meta-analysis.

Xu R, Tao A, Zhang S, Deng Y, Chen G.

Int J Clin Exp Med. 2015 Mar 15;8(3):3924-34. eCollection 2015.

4.

Role of mitochondria in nonalcoholic fatty liver disease.

Nassir F, Ibdah JA.

Int J Mol Sci. 2014 May 15;15(5):8713-42. doi: 10.3390/ijms15058713. Review.

5.

Effects of resveratrol in experimental and clinical non-alcoholic fatty liver disease.

Heebøll S, Thomsen KL, Pedersen SB, Vilstrup H, George J, Grønbæk H.

World J Hepatol. 2014 Apr 27;6(4):188-98. doi: 10.4254/wjh.v6.i4.188. Review.

6.

From fatty liver to fibrosis: a tale of "second hit".

Basaranoglu M, Basaranoglu G, Sentürk H.

World J Gastroenterol. 2013 Feb 28;19(8):1158-65. doi: 10.3748/wjg.v19.i8.1158. Review.

7.

Update on fatty liver disease and steatohepatitis.

Aly FZ, Kleiner DE.

Adv Anat Pathol. 2011 Jul;18(4):294-300. doi: 10.1097/PAP.0b013e318220f59b. Review.

8.

Apoptosis in nonalcoholic fatty liver disease: diagnostic and therapeutic implications.

Alkhouri N, Carter-Kent C, Feldstein AE.

Expert Rev Gastroenterol Hepatol. 2011 Apr;5(2):201-12. doi: 10.1586/egh.11.6. Review.

9.

Presence and significance of microvesicular steatosis in nonalcoholic fatty liver disease.

Tandra S, Yeh MM, Brunt EM, Vuppalanchi R, Cummings OW, Unalp-Arida A, Wilson LA, Chalasani N; NASH Clinical Research Network (NASH CRN).

J Hepatol. 2011 Sep;55(3):654-9. doi: 10.1016/j.jhep.2010.11.021. Epub 2010 Dec 21.

10.

Histopathology of nonalcoholic fatty liver disease.

Brunt EM, Tiniakos DG.

World J Gastroenterol. 2010 Nov 14;16(42):5286-96. Review.

11.

Mechanisms and clinical implications of hepatocyte lipoapoptosis.

Cazanave SC, Gores GJ.

Clin Lipidol. 2010 Feb 1;5(1):71-85.

12.

Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease.

Abdelmalek MF, Suzuki A, Guy C, Unalp-Arida A, Colvin R, Johnson RJ, Diehl AM; Nonalcoholic Steatohepatitis Clinical Research Network.

Hepatology. 2010 Jun;51(6):1961-71. doi: 10.1002/hep.23535.

13.

Lipotoxicity in nonalcoholic fatty liver disease: not all lipids are created equal.

Alkhouri N, Dixon LJ, Feldstein AE.

Expert Rev Gastroenterol Hepatol. 2009 Aug;3(4):445-51. doi: 10.1586/egh.09.32. Review.

14.

JNK1-dependent PUMA expression contributes to hepatocyte lipoapoptosis.

Cazanave SC, Mott JL, Elmi NA, Bronk SF, Werneburg NW, Akazawa Y, Kahraman A, Garrison SP, Zambetti GP, Charlton MR, Gores GJ.

J Biol Chem. 2009 Sep 25;284(39):26591-602. doi: 10.1074/jbc.M109.022491. Epub 2009 Jul 28.

15.

Glycine and urea kinetics in nonalcoholic steatohepatitis in human: effect of intralipid infusion.

Dasarathy S, Kasumov T, Edmison JM, Gruca LL, Bennett C, Duenas C, Marczewski S, McCullough AJ, Hanson RW, Kalhan SC.

Am J Physiol Gastrointest Liver Physiol. 2009 Sep;297(3):G567-75. doi: 10.1152/ajpgi.00042.2009. Epub 2009 Jul 1.

16.

Pioglitazone retrieves hepatic antioxidant DNA repair in a mice model of high fat diet.

Hsiao PJ, Hsieh TJ, Kuo KK, Hung WW, Tsai KB, Yang CH, Yu ML, Shin SJ.

BMC Mol Biol. 2008 Sep 26;9:82. doi: 10.1186/1471-2199-9-82.

17.

The lysosomal-mitochondrial axis in free fatty acid-induced hepatic lipotoxicity.

Li Z, Berk M, McIntyre TM, Gores GJ, Feldstein AE.

Hepatology. 2008 May;47(5):1495-503. doi: 10.1002/hep.22183.

18.

Mammalian Sir2 homolog SIRT3 regulates global mitochondrial lysine acetylation.

Lombard DB, Alt FW, Cheng HL, Bunkenborg J, Streeper RS, Mostoslavsky R, Kim J, Yancopoulos G, Valenzuela D, Murphy A, Yang Y, Chen Y, Hirschey MD, Bronson RT, Haigis M, Guarente LP, Farese RV Jr, Weissman S, Verdin E, Schwer B.

Mol Cell Biol. 2007 Dec;27(24):8807-14. Epub 2007 Oct 8.

19.

Methionine deficiency and hepatic injury in a dietary steatohepatitis model.

Oz HS, Chen TS, Neuman M.

Dig Dis Sci. 2008 Mar;53(3):767-76. Epub 2007 Aug 21.

Items per page

Supplemental Content

Write to the Help Desk